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following the identification of a gene defect in a relative. A third
is accessibility of genetic information by insurers and employers,
particularly as that information relates to the risk factors that go
into the calculation of insurance rates and to the competitive edge
achieved by an employer with a healthy workforce. These are
issues with no easy solutions, and ones that require careful
thought by individuals inside and outside the medical profession
to arrive at solutions that are equitable and acceptable to our
society.
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Autosomal dominant polycystic kidney disease (ADPKD) is
one of the most common hereditaiy disorders and has unique
heterogeneity in both genetic and clinical features. First, a signif-
icant fraction of the ADPKD patient population is not linked to
the PKD1 locus located on the short arm of chromosome 16. It
has been estimated that this group (non-PKD1) constitute about
5 to 15% of all ADPKD patients, and no geographical clustering
has been observed so far. The clinical feature of a non-PKD1
patient is late onset of disease. These patients generally have a
better prognosis compared to PKD1 linked patients. Secondly,
although ADPKD is a progressive disease, end-stage renal disease
will occur in many but not all of the patients with non-PKD1.
Many patients are even asymptomatic.
In a national survey (P < 0.01), 3.9 per million Japanese
ADPKD patients annually develop end-stage renal disease com-
pared to 5.0 ADPKD patients per million patients in the United
States. The difference could be explained by multiple factors such
as race, diet, and medical delivery. ADPKD affects all races,
although whether this genetic heterogeneity exists in Asians has
not been studied.
We conducted a rapid genetic analysis of families with ADPKD
by means of an amplification of a microsatellite marker flanking
the PKD1 locus. The microsatellite D16S283 (SM7), which flanks
PKD1 proximally, was found to be highly polymorphic by Harris
et al. They noticed no recombination between PKD1 and SM7 in
90 informative meiosis. These studies were performed to deter-
mine if presymtomatic diagnosis of PKD1 linkage might make it
possible to intervene progressive renal failure by diet control and
medication. Previous work by other investigators has demon-
strated 11 genotypes of this marker in Caucasians. Nine genotypes
were isolated from the Japanease population tested. A total of 26
patient families (140 family members) were examined and 18
families were informative. Out of these 18 families, 14 (78%)
appeared to be linked to PKD1. Four families (22%) did not
follow PKD1 linkage, provided that no recombination occurred
bewteen PKD1 and SM7.
Although further studies are needed to identify the precise
genetic linkage for each family, the chances to be non-PKD1
linked are considered high in Japanese patients. The prognosis of
non-PKD1 linked patients have been found to be relatively better
compared to PKD1 linked patients. In 14 putitive PKD1 linked
families, 13 families have at least one member on dialysis. The
mean age of end-stage renal failure in this group is 50.8 (SD = 9.6).
In contrast, only one in 4 non-PKD1 linked families has a dialyzed
patient. Six families out of 24 (25%) were not imformative in this
study. Polymorphism was not informative in several cases, and
also the presence of shadow bands in gels sometimes caused
difficulties in the interpretation of genetic linkage.
Opportunities for the detection of ADPKD would be quite
different from country to country according to its medical delivery
system. These studies suggest that non-PKD1 linked families are
more prevelant in Japan as compared to the United States. This
rather ubiquitous presence of non-PKD1 linked families might
contribute to the fact that less ADPKD patients are dialyzed in
Japan compared to the United States.
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Progress in the cloning of ADPKD
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It has been nine years since the most common form of
autosomal dominant polycystic kidney disease was first localized
to a 10-14 CM interval of chromosome 16pl3.3. This important
observation was soon followed by reports of more precise genetic
and physical maps that defined a candidate genomic interval of
approximately 500 kb. By 1991, virtually the entire genomic
segment and over 20 independent sets of candidate cDNA clones
had been isolated, and discovery of the disease gene appeared
imminent.
The PKD1 gene has remained elusive, however. There are a
number of unique aspects of the search for the PKD1 gene that
distinguish it from previous disease gene mapping expeditions and
account for its prolonged course. First, virtually all of the disease
genes successfully cloned to date have had clues betraying their
identity. The majority have been marked by chromosomal dele-
tions, rearrangements, or unstable elements. The remainder have
been identified on the basis of functional properties encoded by
their genes. We and others have searched the PKD1 interval for
similar hints without success. Southern blot hybridization studies
failed to detect disease-specific variants in the genomic restriction
maps for individuals affected with PKDI. A search for unstable
DNA elements also was unsuccessful.
Functional approaches have been limited by our incomplete
understanding of the pathogenesis of this disorder. Abnormalities
of tubular cell growth and differentiation, epithelial polarity, and
basement membrane composition are among the many differ-
ences observed between normal and cystic epithelia. Curiously,
